Nursing Elites

1. What is this surgical procedure that restores blood flow to the heart by diverting blood around a blocked artery?

• A. Coronary artery bypass graft (CABG)
• B. Angioplasty
• C. Stent placement
• D. Valve replacement

Correct answer: A

Rationale: The correct answer is A, Coronary artery bypass graft (CABG), which is a surgical procedure to improve blood flow to the heart by redirecting blood around blocked or narrowed arteries. This procedure is specifically designed to bypass blocked coronary arteries, allowing blood to flow more freely to the heart muscle. Choices B, C, and D are incorrect because angioplasty involves opening up narrowed or blocked blood vessels, stent placement involves inserting a mesh tube to keep arteries open, and valve replacement involves replacing a damaged heart valve - none of which directly address diverting blood flow around a blocked artery.

2. Which heart chamber receives venous blood returning to the heart via the superior and inferior vena cava?

• A. Right atrium
• B. Left atrium
• C. Right ventricle
• D. Left ventricle

Correct answer: A

Rationale: The correct answer is A: Right atrium. The right atrium is the heart chamber that receives deoxygenated blood returning from the body via the superior and inferior vena cava. The blood enters the right atrium from the vena cava and then passes through the tricuspid valve into the right ventricle. Choices B, C, and D are incorrect because the left atrium receives oxygenated blood from the lungs, the right ventricle pumps blood to the lungs for oxygenation, and the left ventricle pumps oxygenated blood to the body.

3. The client on spironolactone (Aldactone) has a potassium level of 5.8 mEq/L. What is the nurse’s priority action?

• A. Hold the spironolactone and notify the healthcare provider.
• B. Administer a potassium supplement.
• C. Continue the spironolactone as ordered.
• D. Increase the dose of spironolactone.

Correct answer: A

Rationale: With a potassium level of 5.8 mEq/L, which is high, the priority action for the nurse is to hold the spironolactone. Spironolactone is a potassium-sparing diuretic that can further increase potassium levels. Therefore, it is crucial to prevent exacerbating hyperkalemia by discontinuing the medication. Notifying the healthcare provider is necessary for further guidance and potential adjustments to the treatment plan. Administering a potassium supplement (Choice B) would be contraindicated since the client already has elevated potassium levels. Continuing the spironolactone as ordered (Choice C) can worsen hyperkalemia. Increasing the dose of spironolactone (Choice D) would be unsafe and exacerbate the high potassium levels.

4. What is a condition where the heart beats too slowly, reducing the amount of blood pumped to the body?

• A. Bradycardia
• B. Tachycardia
• C. Atrial fibrillation
• D. Ventricular fibrillation

Correct answer: A

Rationale: Bradycardia is the correct answer. It is a condition characterized by a slow heart rate, which reduces the amount of blood pumped to the body. This can lead to symptoms like fatigue and dizziness. Choice B, Tachycardia, is the opposite condition where the heart beats too fast. Choices C and D, Atrial fibrillation and Ventricular fibrillation, refer to irregular and potentially life-threatening rapid heart rhythms involving the atria and ventricles respectively, not a slow heart rate.

5. The client on warfarin has an INR of 1.2. What is the nurse’s priority action?

• A. Increase the dose of warfarin
• B. Administer vitamin K
• C. Monitor for signs of bleeding
• D. Hold the next dose and notify the healthcare provider

Correct answer: A

Rationale: The correct answer is to increase the dose of warfarin. An INR of 1.2 is below the therapeutic range for a client on warfarin, indicating that the dose is subtherapeutic. The priority action in this situation is to adjust the dose to achieve the target therapeutic INR range (usually 2-3) to prevent thromboembolic events. Administering vitamin K is not necessary as the INR is low, and there are no signs of bleeding. Monitoring for signs of bleeding is important but not the priority in this case since the INR is subtherapeutic. Holding the next dose and notifying the healthcare provider would delay the intervention needed to adjust the dose and achieve the therapeutic range.

Similar Questions